AUPH — Aurinia Pharmaceuticals Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential tre… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$15.54
Market Cap$1.97B
Float126.2M
Shares Outstanding128.6M
P/E (Forward)20.04
P/E (TTM)7.09
Price/Sales (TTM)6.60
vs. Analyst Target+9.4% to analyst PT
Profit Margin99.97%
Operating Margin (TTM)53.31%
Revenue (TTM)$298M
Earnings Growth (YoY)56.30%
Dividend RateNone
Analyst Target Price$17.00 (6 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $50.1M -$103M $50.1M -$103M
2021 $45.6M -$181M $44.5M -$177M
2022 $134M -$108M $128M -$109M
2023 $176M -$78.0M $161M -$63.0M
2024 $235M $5.8M $207M $31.7M
2025 $283M $287M $250M $128M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $70.0M $21.5M
Sep 2025 $73.5M $31.6M
Dec 2025 $77.1M $211M
Mar 2026 $77.7M $34.4M

Ownership & Float

Insider Ownership7.5%
Institutional Ownership59.5%
Short Float7.0%
% of All Funds Holding2.92%
Number of Funds Holding240

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$15.43Near-term / short-term trend
Weekly40-Week SMA$14.41Medium-term trend
Weekly80-Week SMA$11.51Cyclical trend (business cycle)
Weekly200-Week SMA$9.19Secular trend (multi-year)
Monthly10-Month SMA$14.27Near-term monthly trend
Monthly20-Month SMA$11.28Medium-term monthly trend
Monthly40-Month SMA$9.58Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$13.10 support 1.20x 5 months ago
$9.40 support 1.61x 8 months ago

Historical Earnings Reactions (47 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.46% 0.28% 57.45% 12.55% -13.45%
1 Day 0.54% 0.59% 55.32% 23.14% -17.79%
1 Week -0.23% -1.31% 36.17% 49.61% -49.72%
2 Weeks 0.84% -0.14% 48.94% 47.47% -39.72%
1 Month 5.99% 0.32% 50.00% 273.93% -40.28%

Next earnings: July 26, 2026 (59 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan7.2%33.3%12
Feb0.6%41.7%12
Mar9.0%50.0%12
Apr-0.5%66.7%12
May-0.8%54.5%11
Jun-2.0%45.5%11
Jul4.1%63.6%11
Aug-1.4%54.5%11
Sep6.4%45.5%11
Oct4.9%58.3%12
Nov3.6%58.3%12
Dec9.3%41.7%12

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.08% 46.2% 552
Tuesday 0.04% 44.7% 608
Wednesday 0.18% 47.5% 604
Thursday -0.05% 46.6% 592
Friday 0.50% 49.7% 592

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 59.5%

Insider Transactions — Smart Summary

Total insider ownership: 7.5%

12-Month Insider Activity Summary

Total Filings3
Net Value-$210,000
Net Shares Change2,180,000
% of Float1.7%
C-Suite Filings1
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
TANG KEVIN +$26.3M 2 2 buy
Keenan Greg Chief Medical Officer -$210,000 1 1 sell

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-03-03 TANG KEVIN +$12.7M Transaction at $14.10, now +10.2%
2025-08-05 TANG KEVIN +$13.6M Transaction at $10.45, now +48.7%
2025-08-05 Keenan Greg Chief Medical Officer -$210,000 Transaction at $10.50, now +48.0%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Aurinia Pharmaceuticals Inc (AUPH) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for AUPH on Trend Edge →